[theold]

It follows successful advanced trials in both the United States and Europe, reports Bloomberg. Study results are eliciting better immunity than AstraZeneca’s shot, with fewer side effects.

There is a growing belief that adding VLA2001 to the UK’s portfolio could significantly increase vaccination coverage and make an important contribution to the the fight against the latest developments in the COVID-19 pandemic.


https://dailybusinessgroup.co.uk/2021/11...t-omicron/